Concepedia

Michael Lundemann

ML

Statistics

Publications

17

Citations

817

H-Index

14

Active since

2014

Affiliations

University of Copenhagen(Current)

Rigshospitalet

Copenhagen University Hospital

Bispebjerg Hospital

Odense University Hospital

Michael Lundemann is an author at University of Copenhagen specializing in medicine, oncology, and nuclear medicine.

ORCID

Publications per year

2014–2023

17

Publications

17

Cardiovascular disease after treatment for Hodgkin's lymphoma: an analysis of nine collaborative EORTC-LYSA trials

Maja V. Maraldo, Francesco Giusti, Ivan R. Vogelius et al. · The Lancet Haematology · 2015 · 172 citations

, , +10

Minimizing Late Effects for Patients With Mediastinal Hodgkin Lymphoma: Deep Inspiration Breath-Hold, IMRT, or Both?

Marianne Aznar, Maja V. Maraldo, D.A. Schut et al. · International Journal of Radiation Oncology*Biology*Physics · 2015 · 125 citations

, , +13

The prognostic value of FET PET at radiotherapy planning in newly diagnosed glioblastoma

Sidsel Højklint Poulsen, Thomas Urup, Kirsten Grunnet et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2016 · 76 citations · Full text

, , +17

Feasibility of multi-parametric PET and MRI for prediction of tumour recurrence in patients with glioblastoma

Michael Lundemann, Per Munck af Rosenschöld, Aida Muhic et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2018 · 71 citations

, , +14

Impact of [18F]-fluoro-ethyl-tyrosine PET imaging on target definition for radiation therapy of high-grade glioma

Per Munck af Rosenschöld, Junia C. Costa, Svend Aage Engelholm et al. · Neuro-Oncology · 2014 · 68 citations · Full text

, , +17

1–5 of 17